Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2014
04/24/2014US20140114054 Antibody capable of specifically recognizing transferrin receptor
04/24/2014US20140113836 Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid
04/24/2014US20140113834 Hybridoma clones and monoclonal antibodies to ing4
04/24/2014US20140113370 Fc fusion proteins comprising novel linkers or arrangements
04/24/2014US20140113317 Polyclonal antibodies to cloned fungal polypeptide targets
04/24/2014US20140112942 Agonistic antibody to cd27
04/24/2014US20140112935 Antibodies to interleukin-6 and use thereof
04/24/2014US20140112933 Antibodies Against Angiopoietins 1 and 2, and Their Use
04/24/2014US20140112931 Anti-human her3 antibodies and uses thereof
04/24/2014US20140112930 Methods for Treating or Preventing Malaria by Administering an Antibody that Specifically Binds Angiopoietin-2 (Ang-2)
04/24/2014US20140112929 Tumour necrosis factor receptor 1 antagonists
04/24/2014US20140112928 Antibodies against tropomyosin-related kinase b receptors
04/24/2014US20140112927 Bispecific monoclonal antibody therapeutics against west nile virus with improved cns penetration
04/24/2014US20140112926 Fc VARIANTS
04/24/2014US20140112925 SINGLE CHAIN ANTIGEN RECOGNIZING CONSTRUCTS (scARCs) STABILIZED BY THE INTRODUCTION OF NOVEL DISULFIDE BONDS
04/24/2014US20140112924 Novel ctla4-ig immunoadhesins
04/24/2014US20140112922 Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes
04/24/2014US20140112919 Interleukin-10 antibodies
04/24/2014US20140112916 Optimized Antibodies That Target CD19
04/24/2014US20140112915 IL-18 binding molecules
04/24/2014US20140112914 Cytotoxicity-inducing therapeutic agent
04/24/2014US20140112910 Modified glycoproteins
04/24/2014US20140112865 Anti-CD19 Antibodies
04/24/2014CA2874979A1 Antigen binding proteins that bind dll-4
04/23/2014EP2722343A1 ANTI-erbB3 ANTIBODY
04/23/2014EP2722342A1 Methods and compositions for the treatment of pancreatic cancer
04/23/2014EP2722341A1 Antibodies to interleukin-6 and uses thereof
04/23/2014EP2722055A1 Combination therapy with antibodies and anti-VEGF agents for the treatment of cancer
04/23/2014EP2721073A1 Soluble proteins for use as therapeutics
04/23/2014EP2721071A1 Tem8 antibodies, conjugates thereof, and their use
04/23/2014EP2721070A1 Methods of enhancing the response to radiation in tumor therapy using anti-dll4 antibodies
04/23/2014EP2721069A1 Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer.
04/23/2014EP2721068A1 Selective elimination of erosive cells
04/23/2014EP2721067A1 Anti-human epo receptor antibodies and methods of use
04/23/2014EP2721066A1 Tumour necrosis factor receptor 1 antagonists
04/23/2014EP2721065A1 Anti-angptl3 antibodies and uses thereof
04/23/2014EP2721064A1 Antibody binding to abca1 polypeptide
04/23/2014EP2720768A1 Purification of biological products by constrained cohydration chromatography
04/23/2014EP2720721A1 Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer
04/23/2014CN103748238A Detection of prame gene expression in cancer
04/23/2014CN103748222A Novel anti-human NGF antibody
04/23/2014CN103748114A Bispecific t cell activating antigen binding molecules
04/23/2014CN103748113A Modulators of plexin b2 activity
04/23/2014CN103748112A Antibodies for treatment of cancer expressing claudin 6
04/23/2014CN103748111A Anti-cgrp compositions and use thereof
04/23/2014CN103748110A Antigen-binding proteins with increased FcRn binding
04/23/2014CN103747803A Anti-AXL antibodies and uses thereof
04/23/2014CN103743898A Phosphorylcholine conjugates and corresponding antibodies
04/23/2014CN103740728A Rare codon-transformed human ZNF580 gene and prokaryotic expression protein thereof and polyclonal antibody
04/23/2014CN103740670A Kit for screening glyphosate N-acetyltransferase antiserum
04/23/2014CN103740651A Hybridoma cells capable of secreting anti-GST (glutathione S-transferase) monoclonal antibody, monoclonal antibody and application thereof
04/23/2014CN103740650A Monoclonal antibody BTV16-3G10 resistant to bluetongue virus serum 16 type VP2 protein, B-cell epitope polypeptide identified by monoclonal antibody BTV16-3G10, and applications of monoclonal antibody BTV16-3G10
04/23/2014CN103740649A Monoclonal antibody BTV16-2B4 resistant to bluetongue virus serum 16 type VP2 protein, B-cell epitope identified by monoclonal antibody BTV16-2B4, and applications of monoclonal antibody BTV16-2B4
04/23/2014CN103740648A Kinesin spindle protein (Eg5) monoclonal antibody and hybridoma cell strain secreting it
04/23/2014CN103739711A High affinity human antibodies to human ill-4 receptor
04/23/2014CN103739710A VEGF (Vascular Endothelial Growth Factor) resistant antibody and application thereof
04/23/2014CN103739709A Antibodies against human angiopoietin 2
04/23/2014CN103739708A Infectious haematopoietic necrosis virus resisting monoclonal antibody and application thereof
04/23/2014CN103739707A Humanized antibody for resisting avian influenza H5N1 hemagglutinin antigen, and preparation method and application thereof
04/23/2014CN103739706A Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
04/23/2014CN103739705A New elution method for antibody affinity purification and application thereof
04/23/2014CN103739703A Glycocholic acid immunogen, anti-glycocholic acid specific antibody and detection reagent
04/23/2014CN103739679A Avian metapneumovirus (aMPV) F protein polypeptide and application thereof
04/23/2014CN103739675A Strawberry vein banding virus antibody, and antigen polypeptide, immunogen and application thereof
04/23/2014CN102876635B Haemophilus parasuis outer membrane protein P5 (OMP5) resistant monoclonal antibody, hybridoma cell strain and application
04/23/2014CN102827278B Antitumor protein P53 monoclonal antibody and application thereof
04/23/2014CN102807488B Hapten and antigen universally used for ether pyrethroid pesticide, and synthesis method and application of hapten and antigen
04/23/2014CN102786595B Anti-CD5 monoclonal antibody and purpose thereof
04/23/2014CN102659939B Diphenylhydantoin immunogen, diphenylhydantoin specificity-resistant antibody and diphenylhydantoin detection reagent
04/23/2014CN102449149B A collection and methods for its use
04/23/2014CN102260322B Antigen peptide of Helicobacter pylori and application thereof
04/23/2014CN102239251B Bovine viral diarrhea virus with a modified ERNS protein
04/23/2014CN102140129B 鸡pdx1多克隆抗体及应用 Chicken polyclonal antibody and application pdx1
04/23/2014CN102037362B Methods and antibody for the diagnosis and treatment of hepatocellular carcinoma
04/23/2014CN101325968B Anti-CTLA-4 antibody compositions
04/22/2014US8703920 Fully human antibodies against N-cadherin
04/22/2014US8703919 Glycosylated antibodies
04/22/2014US8703918 Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof
04/22/2014US8703913 Sensor
04/22/2014US8703907 Controlled drug release from dendrimers
04/22/2014US8703906 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
04/22/2014US8703903 Method for quantification of allergens
04/22/2014US8703729 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
04/22/2014US8703714 Monomethylvaline compounds capable of conjugation to ligands
04/22/2014US8703712 Targeting cancer stem cells with DR5 agonists
04/22/2014US8703694 Methods for increasing thermogenic adipocytes
04/22/2014US8703693 Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment
04/22/2014US8703471 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
04/22/2014US8703433 Marker for amyotrophic lateral sclerosis, and use thereof
04/22/2014US8703429 Composition exhibiting a von Willebrand Factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
04/22/2014US8703426 Composition exhibiting a von Willebrand Factor (vWF) protease activity with the amino acid sequence AAGGILHLELLV
04/22/2014US8703149 HCV coreceptor and methods of use thereof
04/22/2014US8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses
04/22/2014US8703141 Method for treating Crohn's disease by administering an anti-IL-12 antibody
04/22/2014US8703140 Inhibition of factor B, the alternative complement pathway and methods related thereto
04/22/2014US8703135 Biological materials related to c-Met
04/22/2014US8703133 Antibody variants
04/22/2014US8703131 Nanobodies against tumor necrosis factor-alpha
04/22/2014US8703129 Antibodies against extended type 1 chain antigens, derivatives thereof and use
04/22/2014US8703125 Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 1494